Page 1249 - Small Animal Clinical Nutrition 5th Edition
P. 1249

INDEX 1301


                     of mature adult cats, 391-392                        evidence in FLUTD, 946, 954t, 955, 955t
                     of mature adult dogs, 275                        Exercise
                     of nursing and orphaned kittens, 420, 420t         amount to feed during, 347-350
        VetBooks.ir  of nursing and orphaned puppies, 299-300, 303t     commercial foods for, 348-349t
                                                                        cost of running, 332, 333b
                     of patients with cancer, 601
                     of patients with cardiovascular disease, 756       energy requirement for, 336-337, 336t
                     of patients with diabetes mellitus, 568-569        environmental influences on, 332-334
                     of patients with renal disease, 795                food adaptation during, 351-352
                     of reproducing cats, 404                           influence of genetics, 321
                     of reproducing dogs, 284-286, 285t                 influence of training, 321-322
                     of working and sporting dogs, 326f, 328f, 332, 332t  intensity and duration, 330, 351t
                     of young adult cats, 377                           key nutritional factors for, 335-345
                     of young adult dogs, 262-263                       physiology, 325-332
                    storage, 55                                         protein requirement for, 341-342
                    use, 54-55                                          types of, 332
                  Enteral-assisted feeding, 439-476                     value in weight-loss programs, 521b
                    commercial veterinary foods for, 469t               water requirement during, 335-336
                    feeding schedules for, 460-463                      when to feed during, 350-351
                    human foods for, 468                              Exocrine pancreatic insufficiency (EPI), 1135-1142
                    key nutritional factors for, 450t                   adjunctive medical management, 1139-1040
                    modules for augmenting foods, 465-467               assessment of, 1135-1137
                    routes of delivery, 457-460                         clinical importance of, 1135
                    selecting foods for, 463-468                        commercial foods for, 1138t, 1139t
                    techniques for, 459b, 460-461b, 462b, 463b, 464b    etiopathogenesis, 1136-1137
                  Enteritis (See Acute gastroenteritis and enteritis)   feeding plan for patients with, 1138-1139
                  Enteropathy                                           key nutritional factors for, 1137, 1137t
                    gluten (gliadin) enteropathy, 1050b                 pancreatic enzyme preparations for patients with, 1139-
                    protein-losing enteropathy, 1077-1084               1140, 1140t
                     assessment of, 1077-1079                           risk factors for, 1136
                     clinical importance of, 1077                     Extruded (dry) pet food, 159-160, 179-183
                     commercial foods for, 1082t                        effects on dental health, 986-989
                     concurrent therapy for, 1081
                     feeding plan for, 1081                           F
                     key nutritional factors for, 1079-1081, 1079t    Fat (See also Lipids)
                     risk factors for, 1078                             effects on drug metabolism, 1200, 1200t, 1203
                  Enterotoxins, Bacillus cereus, 230t, 231, 232         levels for dogs at risk for developmental orthopedic disease,
                  Erythropoietin, 770, 772, 780t, 782t, 801c            682t
                  Escherichia coli, 228, 230t, 231, 232, 240c           relationship to developmental orthopedic disease of dogs,
                  Esophageal disorders (Pharyngeal and esophageal disorders),  676-678
                    1013-1022                                           requirement/recommendation
                    assessment of, 1013-1018                            for patients with cancer, 593t, 595-596
                    breed-associated swallowing disorders, 1016t          of growing cats, 430t, 431
                    clinical importance of, 1013                          of growing dogs, 312t, 313
                    commercial foods for, 1019t, 1020t                    of mature adult cats, 391t, 392-393
                    concurrent therapy for, 1021                          of mature adult dogs, 275, 275t
                    etiopathogenesis of, 1016-1018                        of nursing kittens, 420-421, 425t
                    feeding plan for patients with, 1018-1021             of nursing puppies, 301-302, 303t
                    key nutritional factors for, 1018                     of reproducing cats, 403t, 406
                    mechanisms of, 1016t                                  of reproducing dogs, 284t, 286
                    risk factors for, 1015-1016                           of working and sporting dogs, 336t, 337-339
                  Esophagostomy feeding tubes, 459-460, 463b              of young adult cats, 376t, 377
                  Essential amino acids, (See Amino acids)                of young adult dogs, 261t, 263
                  Essential fatty acids (See Fatty acids)             Fat-soluble vitamins, 98, 103, 123, 126-131
                  Evidence-based clinical nutrition, 23-30            Fatty acids (See also Fat, Lipids)
                    application to specific patients, 25-26             biologic function of, 96, 99t
                    conceptual model, 25f                               chemistry and nomenclature of, 96f
                    EBM concepts, 23-24                                 content of foods and supplements, 654t, 655t, 656t
                    evidence pyramid, 25f                               eicosanoid production from, 653f
                    guidelines, 24t                                     essentiality, 100-102
                    rules of evidence, 24-25                            essential fatty acids, 104
                    treatment decisions, 26-28, 782t, 946, 954t, 955, 955t  deficiency of, 103, 644-645
                     evidence in chronic kidney disease, 782t             functions in the skin, 643-644
   1244   1245   1246   1247   1248   1249   1250   1251   1252   1253   1254